BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24900047)

  • 21. Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review.
    Ganeshan D; Menias CO; Pickhardt PJ; Sandrasegaran K; Lubner MG; Ramalingam P; Bhalla S
    Radiographics; 2018; 38(3):849-866. PubMed ID: 29601266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: A case report and review of literature.
    Solav S; Bhandari R
    Indian J Nucl Med; 2012 Apr; 27(2):119-21. PubMed ID: 23723586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literature.
    Addeo A; Bini R; Viora T; Bonaccorsi L; Leli R
    Int J Surg Case Rep; 2013; 4(8):648-50. PubMed ID: 23774333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Hippel-Lindau Syndrome: Medical Syndrome or Surgical Syndrome? A Surgical Perspective.
    Coco D; Leanza S
    J Kidney Cancer VHL; 2022; 9(1):27-32. PubMed ID: 34963877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral pheochromocytoma as first manifestation of von Hippel-Lindau disease: a case report.
    Catli G; Abaci A; Neumann HC; Altincik A; Demir K; Böber E
    Turk J Pediatr; 2012; 54(5):532-5. PubMed ID: 23427520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.
    Sizdahkhani S; Feldman MJ; Piazza MG; Ksendzovsky A; Edwards NA; Ray-Chaudhury A; Maric D; Merrill MJ; Pacak K; Zhuang Z; Chittiboina P
    Sci Rep; 2017 Jan; 7():40822. PubMed ID: 28094316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up and clinical course of a rare case of von Hippel-Lindau disease: A case report and review of the literature.
    Zou YU; Xu J; Zhang M
    Oncol Lett; 2016 May; 11(5):3273-3278. PubMed ID: 27123102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suprasellar Hemangioblastoma on 68 Ga-DOTATATE PET/CT.
    Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 Nov; 47(11):e700-e701. PubMed ID: 35695763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What the neurosurgeon should know about hemangioblastoma, both sporadic and in Von Hippel-Lindau disease: A literature review.
    Bamps S; Calenbergh FV; Vleeschouwer SD; Loon JV; Sciot R; Legius E; Goffin J
    Surg Neurol Int; 2013 Nov; 4():145. PubMed ID: 24340227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT.
    Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
    Clin Nucl Med; 2016 Oct; 41(10):783-4. PubMed ID: 27454593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.
    Ambrosini V; Campana D; Allegri V; Opocher G; Fanti S
    Clin Nucl Med; 2011 Jan; 36(1):64-5. PubMed ID: 21157217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Hippel-Lindau Disease.
    Findeis-Hosey JJ; McMahon KQ; Findeis SK
    J Pediatr Genet; 2016 Jun; 5(2):116-23. PubMed ID: 27617152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease.
    Prasad V; Tiling N; Denecke T; Brenner W; Plöckinger U
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2014-20. PubMed ID: 27293206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gastroenterological manifestations of von Hippel-Lindau disease].
    Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
    Pol Merkur Lekarski; 2017 Aug; 43(254):53-55. PubMed ID: 28875969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
    Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
    Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary PET/CT Imaging with Somatostatin Analogs [
    Satpati D; Shinto A; Kamaleshwaran KK; Sarma HD; Dash A
    Mol Imaging Biol; 2017 Dec; 19(6):878-884. PubMed ID: 28349291
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.